WAVEMAN · COMPANY

CAH · Cardinal Health Inc

LIVE

TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475

← ALL COMPANIES

CAH

Name: CARDINAL HEALTH INC (CAH) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

CARDINAL HEALTH INC

WHOLESALE & RETAIL · WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES · CIK 0000721371

CONGRESS · 1FORM 144 · 7☆ WATCH

INSIDER NET · 180D

-$59.6M

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

706

13F, latest reported quarter

REVENUE GROWTH

+14.2%

XBRL, annual

NET MARGIN

0.7%

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net -$59.6M over 180 days

-$59.6M over 90 days

below 94% of Wholesale & Retail

CONGRESS

1 member bought in the last year

the lowest in Wholesale & Retail

FUNDS

706 funds added or opened last quarter

more than 94% of Wholesale & Retail

REVENUE

+14.2% year over year

more than 82% of Wholesale & Retail

MARGIN

0.7% net margin

below 53% of Wholesale & Retail

BUYBACKS

$1.4B repurchased, FY to 2026-06-30

more than 96% of Wholesale & Retail

SHORT

2.8% of shares outstanding short · 3.4 days to cover · settled 2026-07-31

more than 50% of Wholesale & Retail

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

Insiders are net sellers: -$59.6M across 7 people in 180 days.

706 funds added or opened positions in the latest 13F quarter, of 1,500 holders.

1 member of Congress reported buying it this year.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN +67.0%

+67.0%12M

INSIDER SELLFORM 144

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

Insiders have filed to sell — before selling.

The record shows a net $59.6M sold by insiders over 180 days, 706 funds added last quarter, 1 Congress member(s) bought in 12 months, $59.5M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

CVNA WMT AMZN SNX RVLV W AZO PSMT WLFC TDUP URBN TTSH

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, CARDINAL HEALTH INC insiders sold a net $59.6M of stock across 84 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER

FILED

VALUE

Hollar Jason M.

Chief Executive Officer

SELL

2026-08-19

6,206.0

$1.4M

Hollar Jason M.

Chief Executive Officer

SELL

2026-08-19

3,457.0

$809.9K

Hollar Jason M.

Chief Executive Officer

SELL

2026-08-19

5,704.0

$1.3M

Hollar Jason M.

Chief Executive Officer

SELL

2026-08-19

6,731.0

$1.6M

Hollar Jason M.

Chief Executive Officer

SELL

2026-08-19

16,187.0

$3.8M

84 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 79 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

BlackRock, Inc.

26,490,633.0 sh

$6.3B

VANGUARD CAPITAL MANAGEMENT LLC

15,292,186.0 sh

$3.6B

WELLINGTON MANAGEMENT GROUP LLP

14,860,271.0 sh

$3.5B

VANGUARD PORTFOLIO MANAGEMENT LLC

13,717,894.0 sh

$3.3B

STATE STREET CORP

11,967,121.0 sh

$2.8B

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

Planned sales · Form 144

Filed before the sale — intent, not a trade

Mary Scherer

FILED 2026-08-19

$546.5K

Aaron Alt

FILED 2026-08-18

$9.9M

Jason Hollar

FILED 2026-08-18

$29.4M

Stephen Mason

FILED 2026-08-18

$8.3M

Jessica Mayer

FILED 2026-08-18

$7.0M

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

Saratoga Health & Biotechnology Fund

$786.0K POSITION · AS OF 2026-02-28

6.8%

LIVE OAK HEALTH SCIENCES FUND

$2.8M POSITION · AS OF 2026-04-30

5.6%

SMI 3Fourteen Full-Cycle Trend ETF

$10.6M POSITION · AS OF 2026-03-31

5.0%

Liberty One Defensive Dividend Growth ETF

$2.4M POSITION · AS OF 2026-04-30

4.8%

Brown Advisory Sustainable Value Fund

$7.6M POSITION · AS OF 2026-03-31

4.4%

Bancreek U.S. Large Cap ETF

$4.6M POSITION · AS OF 2026-02-28

4.2%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Clinical pipeline

ClinicalTrials.gov · 1 registered trials, 0 still enrolling or running — a status change here is dated weeks before the press release

Not applicable

0 ACTIVE

TRIALS MATCHED TO THIS TICKER BY SPONSOR NAME · STUDIES RUN UNDER A SUBSIDIARY'S OWN NAME ARE NOT INCLUDED

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2026-06	2025-06	2024-06	2023-06
REVENUE	$254.2B	$222.6B	$226.8B	$205.0B
GROSS PROFIT	$9.8B	$8.2B	$7.4B	$6.9B
OPERATING INCOME	$2.6B	$2.3B	$1.2B	$752.0M
NET INCOME	$1.7B	$1.6B	$852.0M	$330.0M
EPS (DILUTED)	7.23	6.45	3.45	1.26
OPERATING CASH FLOW	$5.2B	$2.4B	$3.8B	$2.8B
CASH	$4.9B	$3.9B	$5.1B	$4.1B
BUYBACKS	$1.4B	$765.0M	$750.0M	$2.0B
DIVIDENDS PAID	$491.0M	$494.0M	$499.0M	$525.0M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE